Literature DB >> 18275277

Human cytomegalovirus (HCMV) DNAemia in the mother at amniocentesis as a risk factor for iatrogenic HCMV infection of the fetus.

Maria Grazia Revello1, Milena Furione, Maurizio Zavattoni, Beatrice Tassis, Umberto Nicolini, Elisa Fabbri, Giuseppe Gerna.   

Abstract

To investigate whether invasive procedures performed in the presence of human cytomegalovirus (HCMV) DNA in maternal peripheral blood (HCMV DNAemia) represent a risk for iatrogenic transmission of HCMV infection to the fetus, 194 pregnant women undergoing prenatal diagnosis because of a primary HCMV infection and their 199 fetuses were investigated. Overall, 27 (37%) of 73 mothers of uninfected fetuses and 22 (37%) of 59 mothers of infected fetuses were HCMV DNAemia-positive at amniocentesis. Of the 8 mothers of the 8 fetuses with false-negative amniocentesis results, 4 were DNAemia-positive and 4 were DNAemia-negative at amniocentesis. Therefore, maternal HCMV DNAemia is not a significant risk factor for iatrogenic HCMV transmission to the fetus during amniocentesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18275277     DOI: 10.1086/526499

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  5 in total

1.  Overview of the diagnosis of cytomegalovirus infection.

Authors:  S A Ross; Z Novak; S Pati; S B Boppana
Journal:  Infect Disord Drug Targets       Date:  2011-10

2.  Amniocentesis to diagnose congenital cytomegalovirus infection following maternal primary infection.

Authors:  Mara J Dinsmoor; Lida M Fette; Brenna L Hughes; Dwight J Rouse; George R Saade; Uma M Reddy; Donna Allard; Gail Mallett; Elizabeth A Thom; Cynthia Gyamfi-Bannerman; Michael W Varner; William H Goodnight; Alan T N Tita; Maged M Costantine; Geeta K Swamy; Kent D Heyborne; Edward K Chien; Suneet P Chauhan; Yasser Y El-Sayed; Brian M Casey; Samuel Parry; Hyagriv N Simhan; Peter G Napolitano; George A Macones
Journal:  Am J Obstet Gynecol MFM       Date:  2022-05-06

3.  Prevention of maternal cytomegalovirus infection: current status and future prospects.

Authors:  Jessica L Nyholm; Mark R Schleiss
Journal:  Int J Womens Health       Date:  2010-08-09

Review 4.  Performance of Zika Assays in the Context of Toxoplasma gondii, Parvovirus B19, Rubella Virus, and Cytomegalovirus (TORCH) Diagnostic Assays.

Authors:  Bettie Voordouw; Barry Rockx; Thomas Jaenisch; Pieter Fraaij; Philippe Mayaud; Ann Vossen; Marion Koopmans
Journal:  Clin Microbiol Rev       Date:  2019-12-11       Impact factor: 26.132

5.  Assessment of HCMV-encoded microRNAs in plasma as potential biomarkers in pregnant women with adverse pregnancy outcomes.

Authors:  Zhiying Gao; Likun Zhou; Jing Bai; Meng Ding; Deshui Liu; Shaohai Zheng; Yuewen Li; Xiulan Li; Xiaojuan Wang; Ming Jin; Huizi Shangting; Changchun Qiu; Cheng Wang; Xiaojie Zhang; Chenyu Zhang; Xi Chen
Journal:  Ann Transl Med       Date:  2021-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.